With a boost from William Shatner, Priceline is heading at warp speed to be the S&P's first $1,000 stock, surprisingly with a reasonable valuation, investors and analysts say.
The "Bespoke 50," a concentrated growth portfolio of small-cap stocks, has jumped 65 percent over the past 18 months, more than double the S&P 500's gain.
The automaker is on a path to become the favored auto brand of the world after demonstrating strong quarterly results in all major global regions, and that could seriously lift shares.
These low-profile names aren't followed by many analysts. But big-name money managers in the know view these stocks as some of the best opportunities in the market.
Individual investors showed no fear during the June stock market pullback, aggressively buying the dip and getting even more bullish by the end of the month than they were before it started. Do they know something the pros don't?
Despite the carnage, the best opportunity may be to buy US Treasurys as inflation stays anemic and the economy continues to limp, note two bond investors.
John Paulson, whose 2007 bet against subprime mortgage securities became known as "The Greatest Trade Ever," is now betting on housing.
The dream used to be a house you paid for with a steady paycheck. But fewer hours worked at lower-wage jobs is severely altering that, especially for young people.
Airline stocks such are set to soar on better-than-expected earnings as consumer confidence increases, capacity continues to come offline and fuel costs remain tame.
Jim Cramer breaks down why last week's sell-off is making Yum Brands' stock an attractive buy into weakness.
Jim Cramer zips through his take on callers' favorite stocks, including a technology hardware giant in the throes of marketwide weakness.
Jim Cramer sits down with MedMen co-founder and CEO Adam Bierman, whose cannabis retailer will absorb PharmaCann in the largest marijuana-related acquisition in U.S. history.